Rubia (2022) Apr 2026

The request likely refers to the academic review article published by Katya Rubia in the journal Psychiatry and Clinical Neurosciences in 2022. Article Overview

The review synthesizes three decades of research, specifically focusing on the transition from identifying brain differences in ADHD through MRI to targeting those deficits with modern neurotherapeutics. Rubia (2022)

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more Neurotherapeutics for ADHD: Do they work? - Rubia - 2022 The request likely refers to the academic review

: The review evaluates several non-pharmacological treatments, including: For medical advice or diagnosis, consult a professional

: Including repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS). Efficacy and Limitations :

The review concludes that while these treatments are attractive due to their compared to stimulant medication, results have been inconsistent.

: Rubia suggests that "one-size-fits-all" approaches are likely to fail. Future success depends on personalizing treatment based on a patient’s neurocognitive or brain-imaging patterns. Clinical Context